Cloud Alpha Capital Management Limited Gracell Biotechnologies Inc. Transaction History

Cloud Alpha Capital Management Limited

  • $839 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$5.65 - $14.9 $423,750 - $1.12 Million
-75,000 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$9.91 - $14.84 $2.13 Million - $3.19 Million
-215,000 Reduced 74.14%
75,000 $1.04 Million
Q2 2021

Aug 13, 2021
BUY
$9.75 - $18.42 $2.83 Million - $5.34 Million
290,000 New
290,000 $3.77 Million

Others Institutions Holding GRCL

# of Institutions
2
Shares Held
75.1K
Call Options Held
0
Put Options Held
0
View Full List

About Gracell Biotechnologies Inc.

GRCL Quotes by TradingView
  • Ticker GRCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,674,096
  • Description
  • Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...
More about GRCL
Track This Portfolio

Track Cloud Alpha Capital Management Limited Portfolio

Follow Cloud Alpha Capital Management Limited and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Alpha Capital Management Limited, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Alpha Capital Management Limited with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email